Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Adenosquamous × Cetuximab × 1 year × Clear all

Sponsor

Conditions

Colorectal Neoplasms 71 Squamous Cell Carcinoma of Head and Neck 52 Carcinoma, Non-Small-Cell Lung 23 Head and Neck Neoplasms 22 Colonic Neoplasms 20 Neoplasm Metastasis 14 Neoplasms 13 Rectal Neoplasms 12 Lung Neoplasms 9 Pancreatic Neoplasms 8 Mouth Neoplasms 7 Laryngeal Neoplasms 6 Hypopharyngeal Neoplasms 6 Carcinoma 6 Solid Tumors 5 Parkinson Disease 4, Autosomal Dominant Lewy Body 5 Oropharyngeal Neoplasms 5 Breast Neoplasms 5 Ovarian Neoplasms 4 Gastrointestinal Neoplasms 4 Endometrial Neoplasms 4 Tongue Neoplasms 3 Recurrence 3 Melanoma 3 Colorectal Cancer Metastatic 3 Carcinoma, Squamous Cell 3 Carcinoma, Renal Cell 3 Carcinoma, Pancreatic Ductal 3 Uterine Cervical Neoplasms 2 Triple Negative Breast Neoplasms 2

Interventions

11-(2-methylpropyl)-12,13-dihydro-2-methyl-8-(pyrimidin-2-ylamino)-4H-indazolo(5,4-a)pyrrolo(3,4-c)carbazol-4-one 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡